Loading clinical trials...
Loading clinical trials...
Smartphone-based Meditation Training to Reduce Adolescent Depression
This study is being done to see if the Healthy Minds Program app helps adolescents with elevated depressive symptoms. Up to 200 participants will be on study for 20 weeks.
Participants will be randomized into one of two groups: Healthy Minds Program intervention group (HMP) or a water tracking active control group. The groups will use different mobile health apps for eight weeks. All participants will complete assessments pre-intervention, after weeks 2, 4, and 6 of the intervention, at week 8 (post-intervention), and at week 20 (follow-up). Participants will complete a short daily diary set of questions on their social interactions that day. Participants will wear a Biostrap band for continuous collection of heart rate, movement, and daily sleep indices, and geolocation data will be extracted from participant phones using the FollowMee app. Participants will receive access to the app they were not assigned to after follow-up. Primary Objective * Assess acceptability and preliminary efficacy of an 8-week mHealth meditation training program on depressive symptoms. Secondary Objectives * Investigate effects of the meditation training program on symptoms of anxiety, behavior (social isolation), psychophysiological processes related to health and disease (e.g., sleep). Test changes in behavior and psychophysiology as mechanisms of improved mental health. Test whether improved mental health is associated with improved academic outcomes.
Age
14 - 19 years
Sex
ALL
Healthy Volunteers
No
Center for Healthy Minds, University of Wisconsin Madison
Madison, Wisconsin, United States
Start Date
December 7, 2024
Primary Completion Date
January 1, 2027
Completion Date
January 1, 2027
Last Updated
January 7, 2026
200
ESTIMATED participants
Healthy Minds Program App
OTHER
Hydro Coach App
OTHER
Lead Sponsor
University of Wisconsin, Madison
Collaborators
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions